Results 211 to 220 of about 15,739 (221)

Regaining control: The patient experience of supervised compared with unsupervised consumption in opiate substitution treatment

Drug and Alcohol Review, 2014
Caitlin Notley, Richard Holland, Christos Kouimtsidis   +2 more
exaly  

Treatment satisfaction and quality of support in outpatient substitution treatment: opiate users’ experiences and perspectives

Drugs: Education, Prevention and Policy, 2015
Wouter Vanderplasschen, Jan Naert, Jessica De Maeyer   +2 more
exaly  

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Addiction, 2011
Katy M E Turner, Sharon J Hutchinson, Peter T Vickerman   +2 more
exaly  

The politics of place(ment): Problematising the provision of hepatitis C treatment within opiate substitution clinics

Social Science and Medicine, 2012
Jake Rance, Jamee Newland, Carla Treloar
exaly  

Cancer treatment and survivorship statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Kimberly D Miller, Leticia Nogueira, Angela B Mariotto   +2 more
exaly  

Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

New England Journal of Medicine, 2003
exaly  

Cancer treatment and survivorship statistics, 2016

Ca-A Cancer Journal for Clinicians, 2016
Kimberly D Miller, Rebecca L Siegel, Chun Chieh Lin   +2 more
exaly  

Cancer treatment and survivorship statistics, 2014

Ca-A Cancer Journal for Clinicians, 2014
Carol E Desantis, Chun Chieh Lin, Angela B Mariotto   +2 more
exaly  

Uptake of and virological response to antiretroviral therapy among HIV‐infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study

HIV Medicine, 2009
exaly  

Patients receiving opiate substitution have elevated mortality risks at the start and end of treatment

Evidence-Based Mental Health, 2011
openaire   +2 more sources